ITRM20080342A1 - Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. - Google Patents
Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso.Info
- Publication number
- ITRM20080342A1 ITRM20080342A1 IT000342A ITRM20080342A ITRM20080342A1 IT RM20080342 A1 ITRM20080342 A1 IT RM20080342A1 IT 000342 A IT000342 A IT 000342A IT RM20080342 A ITRM20080342 A IT RM20080342A IT RM20080342 A1 ITRM20080342 A1 IT RM20080342A1
- Authority
- IT
- Italy
- Prior art keywords
- dolls
- insulation
- use methods
- pulp cells
- similar pulp
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000009413 insulation Methods 0.000 title 1
- 102100022464 5'-nucleotidase Human genes 0.000 abstract 1
- 102100022749 Aminopeptidase N Human genes 0.000 abstract 1
- 102100032912 CD44 antigen Human genes 0.000 abstract 1
- 102100022002 CD59 glycoprotein Human genes 0.000 abstract 1
- 101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 abstract 1
- 102100037241 Endoglin Human genes 0.000 abstract 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 abstract 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 abstract 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 abstract 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 abstract 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 abstract 1
- 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 abstract 1
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 abstract 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 abstract 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 abstract 1
- 102100025323 Integrin alpha-1 Human genes 0.000 abstract 1
- 102100032818 Integrin alpha-4 Human genes 0.000 abstract 1
- 102100025304 Integrin beta-1 Human genes 0.000 abstract 1
- 101100257363 Mus musculus Sox2 gene Proteins 0.000 abstract 1
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 abstract 1
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 abstract 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 abstract 1
- VYXXMAGSIYIYGD-NWAYQTQBSA-N propan-2-yl 2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(pyrimidine-4-carbonylamino)phosphoryl]amino]-2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)(C)NP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)NC(=O)c1ccncn1 VYXXMAGSIYIYGD-NWAYQTQBSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000342A ITRM20080342A1 (it) | 2008-06-26 | 2008-06-26 | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
| US13/000,344 US20110158962A1 (en) | 2008-06-26 | 2009-06-26 | Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| EP09769343A EP2313493A1 (en) | 2008-06-26 | 2009-06-26 | Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| CN2009801335654A CN102131918A (zh) | 2008-06-26 | 2009-06-26 | 牙髓髓相似细胞(dpmsc)和分离和使用的方法 |
| PCT/EP2009/058015 WO2009156495A1 (en) | 2008-06-26 | 2009-06-26 | Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| JP2011515396A JP2011525798A (ja) | 2008-06-26 | 2009-06-26 | 歯髄類似細胞（ｄｐｍｓｃ）ならびにその単離および使用の方法 |
| US15/046,306 US10421947B2 (en) | 2008-06-26 | 2016-02-17 | Dental pulp marrow similar cells (DPMSC) and methods of isolating and using |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000342A ITRM20080342A1 (it) | 2008-06-26 | 2008-06-26 | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITRM20080342A1 true ITRM20080342A1 (it) | 2009-12-27 |
Family
ID=40302081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000342A ITRM20080342A1 (it) | 2008-06-26 | 2008-06-26 | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110158962A1 (https=) |
| EP (1) | EP2313493A1 (https=) |
| JP (1) | JP2011525798A (https=) |
| CN (1) | CN102131918A (https=) |
| IT (1) | ITRM20080342A1 (https=) |
| WO (1) | WO2009156495A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20080342A1 (it) | 2008-06-26 | 2009-12-27 | Univ Degli Studi Udine | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
| US20150335400A1 (en) * | 2009-06-17 | 2015-11-26 | The Trustees Of Columbia University In The City Of New York | Tooth scaffolds |
| US9550975B2 (en) * | 2009-07-15 | 2017-01-24 | Mari Dezawa | SSEA-3 pluripotent stem cell isolated from body tissue |
| ES2360434B1 (es) | 2009-07-21 | 2012-04-12 | Universitat Internacional De Catalunya | Celulas madre pluripotenciales obtenidas a partir de la pulpa dental. |
| JP5608927B2 (ja) * | 2010-04-13 | 2014-10-22 | 国立大学法人名古屋大学 | 歯髄幹細胞を用いた神経疾患治療用組成物 |
| US9719068B2 (en) | 2010-05-06 | 2017-08-01 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into intestinal tissues through directed differentiation |
| EP2633870B1 (en) * | 2012-02-29 | 2018-08-01 | Technische Universität Berlin | Method of preparing an artificial tooth primordium in vitro and artificial tooth primordium derived therefrom |
| WO2013131012A1 (en) * | 2012-03-01 | 2013-09-06 | University Of Miami | Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues |
| JP6193214B2 (ja) | 2012-03-29 | 2017-09-06 | Ｊｃｒファーマ株式会社 | 歯髄由来の多能性幹細胞の製造方法 |
| US10709741B2 (en) | 2013-02-13 | 2020-07-14 | National University Corporation Nagoya University | Composition for preventing or treating inflammatory disease |
| US9790468B2 (en) | 2013-03-15 | 2017-10-17 | Avita Iinternational Ltd. | Multifunctional immature dental pulp stem cells and therapeutic applications |
| US11207352B2 (en) | 2013-03-15 | 2021-12-28 | Avita International Ltd. | Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease |
| US11306290B2 (en) | 2013-03-15 | 2022-04-19 | Avita International Ltd. | Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof |
| US11278574B2 (en) * | 2013-03-15 | 2022-03-22 | Avita International Ltd. | Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease |
| WO2017153956A1 (en) * | 2016-03-09 | 2017-09-14 | Avita International Ltd. | Uses of dental pulp stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease |
| CN106661548B (zh) | 2014-05-28 | 2020-12-11 | 儿童医院医疗中心 | 用于经由定向分化将前体细胞转化为胃组织的方法和系统 |
| JP6909154B2 (ja) * | 2014-08-14 | 2021-07-28 | アヴィタ・インターナショナル・リミテッド | 幹細胞組成物および療法適用のための幹細胞を産生する方法 |
| JP6804438B2 (ja) | 2014-10-17 | 2020-12-23 | チルドレンズ ホスピタル メディカル センター | 多能性幹細胞を使用するヒト小腸のｉｎ ｖｉｖｏモデル、並びにそれを作製、及び使用する方法 |
| CN106471371B (zh) * | 2014-12-05 | 2018-05-04 | 宣捷生物科技股份有限公司 | 区别间充质干细胞的方法 |
| CN105063089A (zh) * | 2015-05-19 | 2015-11-18 | 西安交通大学 | hTERT重组慢病毒永生化人脱落乳牙牙髓干细胞系的方法 |
| KR102729404B1 (ko) | 2016-11-04 | 2024-11-14 | 칠드런즈 호스피탈 메디칼 센터 | 간 유사 장기 조성물 및 이를 제조 및 사용하는 방법 |
| JP7068305B2 (ja) | 2016-12-05 | 2022-05-16 | チルドレンズ ホスピタル メディカル センター | 結腸オルガノイドならびにその作製方法および使用方法 |
| US20200270579A1 (en) * | 2017-02-03 | 2020-08-27 | Kyushu University, National University Corporation | Method for preparing dental pulp stem cells from cells derived from dental pulp tissue |
| US12281334B2 (en) | 2017-04-14 | 2025-04-22 | Children's Hospital Medical Center | Multi donor stem cell compositions and methods of making same |
| EP3694603B1 (en) | 2017-10-10 | 2026-04-08 | Children's Hospital Medical Center | Esophageal tissue and/or organoid compositions and methods of making same |
| EP3708175A4 (en) * | 2017-11-09 | 2021-07-28 | Sapporo Medical University | MEDICINAL PRODUCT FOR TISSUE REGENERATION, AND ITS PREPARATION PROCESS |
| US12379372B2 (en) | 2017-12-21 | 2025-08-05 | Children's Hospital Medical Center | Digitalized human organoids and methods of using same |
| KR102887406B1 (ko) | 2018-07-26 | 2025-11-19 | 칠드런즈 호스피탈 메디칼 센터 | 간-담도-췌장 조직 및 이를 제조하는 방법 |
| CA3103769A1 (en) * | 2018-07-31 | 2020-02-06 | Jcr Pharmaceuticals Co., Ltd. | Method for producing dental pulp-derived cells |
| AU2019339410A1 (en) | 2018-09-12 | 2021-04-15 | Children's Hospital Medical Center | Organoid compositions for the production of hematopoietic stem cells and derivatives thereof |
| WO2020160371A1 (en) | 2019-02-01 | 2020-08-06 | The University Of Hong Kong | Innervated organoid compositions and methods of making same |
| WO2020243633A1 (en) | 2019-05-31 | 2020-12-03 | Children's Hospital Medical Center | Shaped organoid compositions and methods of making same |
| WO2020243613A1 (en) | 2019-05-31 | 2020-12-03 | Children's Hospital Medical Center | Methods of generating and expanding hematopoietic stem cells |
| CN114736957B (zh) * | 2022-04-15 | 2024-03-12 | 中国人民解放军空军军医大学 | 外泌体介导rna casc15干预阿尔茨海默症突触损失的应用 |
| WO2023227972A1 (en) * | 2022-05-24 | 2023-11-30 | Iceta - Instituto De Ciências, Tecnologias E Agroambiente Da Universidade Do Porto | Process for preparation and cryopreservation of dental pulp from definitive teeth and products thereof based on isolated mesenchymal stem cells |
| EP4600350A1 (en) * | 2022-10-03 | 2025-08-13 | Kidswell Bio Corporation | Novel dental pulp stem cell population |
| WO2024075145A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 新規な歯髄幹細胞集団 |
| TW202434721A (zh) * | 2023-02-14 | 2024-09-01 | 國立大學法人山口大學 | 細胞群、三維細胞培養體、醫藥組成物、胞泌體及製作此細胞群的方法 |
| CN117363565B (zh) * | 2023-09-28 | 2024-05-17 | 南方医科大学口腔医院 | 一种用于骨再生的血管化干细胞球的构建方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050106724A1 (en) * | 2002-02-06 | 2005-05-19 | Joerg Schierholz | Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| ES2366085T3 (es) | 2003-04-19 | 2011-10-17 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Células madre postnatales y usos de las mismas. |
| ES2515818T3 (es) * | 2003-11-20 | 2014-10-30 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Células madre multipotentes postnatales de ligamento periodontal humano y sus usos |
| ITNA20040043A1 (it) * | 2004-07-28 | 2004-10-28 | Francesco Carinci | Tecnica di ingegneria tissutale ottenibile mediante isolamento di una nuova sottopopolazione di cellule staminali mbp-shed ed mbp-dpsc, isolate da polpa di denti decidui e permanenti in grado di produrre in vitro tessuto osseo umano. |
| EP1705245B1 (en) | 2005-03-23 | 2009-05-20 | Stiftung CAESAR | Neural stem cells |
| US20070258957A1 (en) * | 2006-05-04 | 2007-11-08 | Russell Bowermaster | Method for obtaining and storing multipotent stem cells |
| EP1748066B1 (en) * | 2005-07-29 | 2008-12-31 | Stiftung CAESAR | Method for isolating stem cells from a pad-like tissue of teeth |
| WO2007117472A2 (en) * | 2006-04-07 | 2007-10-18 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells |
| KR20090031895A (ko) * | 2006-06-09 | 2009-03-30 | 안트로제네시스 코포레이션 | 태반 니치 및 줄기 세포 배양을 위한 이의 용도 |
| ITRM20080342A1 (it) | 2008-06-26 | 2009-12-27 | Univ Degli Studi Udine | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
-
2008
- 2008-06-26 IT IT000342A patent/ITRM20080342A1/it unknown
-
2009
- 2009-06-26 EP EP09769343A patent/EP2313493A1/en not_active Withdrawn
- 2009-06-26 JP JP2011515396A patent/JP2011525798A/ja active Pending
- 2009-06-26 CN CN2009801335654A patent/CN102131918A/zh active Pending
- 2009-06-26 US US13/000,344 patent/US20110158962A1/en not_active Abandoned
- 2009-06-26 WO PCT/EP2009/058015 patent/WO2009156495A1/en not_active Ceased
-
2016
- 2016-02-17 US US15/046,306 patent/US10421947B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011525798A (ja) | 2011-09-29 |
| CN102131918A (zh) | 2011-07-20 |
| EP2313493A1 (en) | 2011-04-27 |
| WO2009156495A1 (en) | 2009-12-30 |
| US20160244724A1 (en) | 2016-08-25 |
| US10421947B2 (en) | 2019-09-24 |
| US20110158962A1 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM20080342A1 (it) | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. | |
| CL2019000540A1 (es) | Método para aislar células madre mesenquimales a partir de membrana amniótica de cordón umbilical utilizando un medio de cultivo celular resumen de la invención. | |
| IL287553B1 (en) | Modified pluripotent cells | |
| WO2008121894A3 (en) | Endogenous expression of hla-g and/or hla-e by mesenchymal cells | |
| EP4004201A4 (en) | SINGLE CELL ANALYSIS | |
| EP4287191A3 (en) | Hla-based methods and compositions and uses thereof | |
| WO2012040465A3 (en) | Multipotent stem cells and uses thereof | |
| WO2012070014A3 (en) | Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells | |
| WO2007146106A3 (en) | Procurement, isolation and cryopreservation of maternal placental cells | |
| ZA200905374B (en) | Hepatocyctes and chondrocytes from adherent placental stem cells;and cd34+cd45-placental stem cell-enriched cell populations | |
| MY173526A (en) | Novel anti-?5?1 antibodies and uses thereof | |
| MX2009008211A (es) | Agentes que capturan celulas que presentan antigenos mediante un receptor de asialoglicoproteina de celula dendritica (dc-asgpr). | |
| MX2020005214A (es) | Formulaciones de anticuerpos. | |
| WO2009102569A3 (en) | Cell lines and methods for making and using them | |
| NO20080991L (no) | Bazedoksifen acetat formuleringer | |
| WO2009039189A3 (en) | Compositions comprising stat3 sirna and methods of use thereof | |
| BRPI0915092A2 (pt) | composição de frutooligossacarídeo, processo para sua produção e uso | |
| RU2014129756A (ru) | Индуцированные плюрипотентные стволовые клетки из клеток, полученных из ткани пуповины человека | |
| GEP20125586B (en) | Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine | |
| WO2011047058A3 (en) | Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same | |
| TW200740518A (en) | Improvements in process operations | |
| WO2010141833A3 (en) | Vital fluorochrome conjugates and methods of use | |
| WO2012030854A3 (en) | Compositions and methods for modulating emt and uses thereof | |
| IN2012DN01379A (https=) | ||
| MX2009008903A (es) | Composiciones de limpieza que comprenden alfa-galactosidasa. |